Test Price
2,800 AED✅ Home Collection Available
RPS6KA3 Gene Mental Retardation, X-Linked Type 19 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل فحص الحمض النووي لجين RPS6KA3 المرتبط بالتخلف العقلي المرتبط بالكروموسوم X من النوع 19 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next Generation Sequencing (Cert: INT/EGQ/2509DA/3139).
دقة تشخيصية بنسبة 99.9٪ عبر معايير الآيزو 9001:2015
Premium Logistics: Paid Hospital‑Grade Home Collection (8 AM–11 PM) with ISO Certified Cold‑Chain Transport & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Interpretation Assistance with a Registered Medical Geneticist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The RPS6KA3 NGS test is a state‑of‑the‑art genetic examination designed to detect mutations in the RPS6KA3 gene responsible for X‑linked intellectual disability type 19. Powered by Next Generation Sequencing technology, it offers a definitive molecular diagnosis, enabling tailored clinical management and informed family planning. فحص جيني متطور لتحديد الطفرات المرتبطة بالتخلف العقلي المرتبط بالكروموسوم X.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – full coding region coverage | Sanger sequencing of limited exons |
| Analytical Sensitivity | >99.9% for single nucleotide variants and small indels | ~95% for targeted regions |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks |
| Price | 2800 AED | ~2000 AED |
Physician Insight & Safety Protocol
"As a clinical geneticist, I understand that pursuing a genetic diagnosis for X‑linked intellectual disability can be emotionally challenging for families. While this NGS test provides definitive molecular answers, it must be correlated with clinical history and multidisciplinary input. Please do not discontinue any prescribed medications or interventions without explicit consultation with your managing neurologist."
— Dr. Prabhakar Reddy, DHA License No: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are not a substitute for ongoing clinical care.
Safety Exclusion Criteria & Emergency Red Flags
- Uncontrolled bleeding disorder precluding safe phlebotomy.
- Lack of valid informed consent in compliance with UAE Federal Decree‑Law No. (41) of 2024 on genetic testing.
- Acute febrile illness, seizure activity within 24 hours, or hemodynamic instability.
- Minors under 6 months of age due to venous access challenges – alternative micro‑sample collection may be arranged.
- Red flag: Any suspicion of non‑accidental injury must be escalated to child protection services before testing proceeds (CDS Law 2026).
Patient FAQ & Clinical Guidance
What is the RPS6KA3 gene test, and why would a neurologist order it?
The RPS6KA3 NGS test is a genetic analysis that screens for mutations in the RPS6KA3 gene linked to X‑linked intellectual disability type 19, providing a definitive molecular diagnosis for tailored neurological care.
ما هو فحص جين RPS6KA3 ولماذا يطلبه طبيب الأعصاب؟
الفحص هو تحليل جيني يبحث عن الطفرات في جين RPS6KA3 المرتبط بالتخلف العقلي المرتبط بالكروموسوم X من النوع 19، ويوفر تشخيصًا جزيئيًا دقيقًا لتوجيه الرعاية العصبية.
How is the test performed, and what sample is required?
A simple blood draw, extracted DNA sample, or a dried blood spot on an FTA card is collected during a hospital‑grade home visit or at our ISO‑certified facility, with the entire process taking less than 10 minutes.
كيف يتم إجراء الفحص وما هي العينة المطلوبة؟
يتم جمع عينة دم بسيطة أو حمض نووي مستخلص أو بقعة دم جافة على بطاقة FTA خلال زيارة منزلية بمعايير المستشفيات أو في منشأتنا المعتمدة آيزو، وتستغرق العملية أقل من 10 دقائق.
What legal and ethical safeguards apply to this genetic test in the UAE?
The test strictly follows Federal Decree‑Law No. (41) of 2024 on genetic data consent, UAE PDPL privacy requirements, and CDS Law 2026 for minors, ensuring all results are securely stored and released only to authorised clinicians.
ما الضوابط القانونية والأخلاقية المطبقة على هذا الفحص الجيني في الإمارات؟
يتبع الفحص بدقة المرسوم بقانون اتحادي رقم (41) لسنة 2024 بشأن الموافقة على البيانات الجينية، ومتطلبات الخصوصية وفق قانون حماية البيانات الشخصية الإماراتي، وقانون الطفل (CDS لعام 2026) للقُصّر، مما يضمن تخزين النتائج بشكل آمن وإصدارها فقط للأطباء المصرح لهم.
UAE Compliance: Genetic testing performed under DHA Facility License No. 9834453, with informed consent mandated by Federal Decree‑Law No. (41) of 2024 (Art. 87) and UAE Personal Data Protection Law. Minors are protected under CDS Law 2026.
ISO 9001:2015 Certified: Cert. INT/EGQ/2509DA/3139 – Global quality assurance for clinical genomics.
Pre‑ Requirement: A qualified genetic counsellor will conduct a session to draw a detailed family pedigree of individuals affected by RPS6KA3‑related intellectual disability, ensuring appropriate clinical context before sample collection.
Contact: WhatsApp & Phone +971 54 548 8731 | Home Collection: 8 AM – 11 PM daily.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians